<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">J. Martin</style></author><author><style face="normal" font="default" size="100%">A. Daas</style></author><author><style face="normal" font="default" size="100%">C. Milne</style></author><author><style face="normal" font="default" size="100%">Alexandre Dobly (contributing scientist)</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated)</style></title></titles><keywords><keyword><style  face="normal" font="default" size="100%">poliomyelitis vaccine (inactivated); D antigen; biological reference preparation; European Pharmacopoeia; collaborative study; in vitro assay</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Dec 2016</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">149</style></number><publisher><style face="normal" font="default" size="100%">EDQM</style></publisher><pub-location><style face="normal" font="default" size="100%">Strasbourg, France</style></pub-location><volume><style face="normal" font="default" size="100%">Pharmeuropa Bio&amp;SN </style></volume><pages><style face="normal" font="default" size="100%">16</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">December</style></issue><accession-num><style face="normal" font="default" size="100%">NA</style></accession-num><section><style face="normal" font="default" size="100%">135</style></section></record></records></xml>